Article
Ivacaftor therapy post myocardial infarction augments systemic inflammation and evokes contrasting effects with respect to tissue inflammation in brain and lung.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jun 2023
Vanherle Lotte, Matthes Frank, Uhl Franziska E, Meissner Anja
Abstract excerpt
Acquired cystic fibrosis transmembrane regulator (CFTR) dysfunctions have been associated with several conditions, including myocardial infarction (MI). Here, CFTR is downregulated in brain, heart, and lung tissue and associates with inflammation and degenerative processes. Therapeutically increasing CFTR expression attenuates these effects. Whether potentiating CFTR function yields similar beneficial effects...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
